0 items USD 0.00Search
Your search for "Breast%20Cancer%20Therapeutics" gave back 38611 results.
The global Breast Cancer Therapeutic market was valued at US$ 596.3 million in 2023 and is anticipated to reach US$ 811.6 million by 2030, witnessing...
Catalog:
MRRPB5
February 2024
Price: USD 2,900.00
Market Analysis and Insights: Global Breast Cancer Therapeutic Market The global Breast Cancer Therapeutic market is projected to grow from US$ 20290...
Catalog:
MRRPB5
June 2023
Price: USD 4,900.00
Medicines include tamoxifen (Nolvadex) for women before and after menopause and aromatase inhibitors including anastrozole (Arimidex), exemestane (...
Catalog:
MRRPB5
May 2023
Price: USD 4,900.00
The “Breast Cancer Therapeutic Industry Forecast” looks at past sales and reviews total world Breast Cancer Therapeutic sales in 2022, providing a...
Catalog:
LPI
March 2023
Price: USD 3,660.00
Medicines include tamoxifen (Nolvadex) for women before and after menopause and aromatase inhibitors including anastrozole (Arimidex), exemestane (...
Catalog:
MRRPB5
October 2023
Price: USD 2,900.00
The global Breast Cancer Therapeutic market is projected to reach US$ 811.6 million in 2029, increasing from US$ 596.3 million in 2022, with the CAGR...
Catalog:
MRRPB5
October 2023
Price: USD 2,900.00
The global Breast Cancer Immunotherapy market is projected to reach US$ 60140 million in 2029, increasing from US$ 22610 million in 2022, with the...
Catalog:
MRRPB5
August 2023
Price: USD 2,900.00
The global Breast Cancer Immunotherapy market size is expected to reach $ 59490 million by 2029, rising at a market growth of 14.4% CAGR during the...
Catalog:
GIR
August 2023
Price: USD 4,480.00
The breast cancer recurrence score test is a genomic test that extracts breast cancer tissue during surgery to check the activity of certain genes...
Catalog:
MRRPB5
February 2024
Price: USD 2,900.00
HR+/HER2-Breast Cancer Market Analysis and Insights: Global HR+HER2- Breast Cancer Market The global HR+HER2- Breast Cancer market is projected to...
Catalog:
MRRPB5
August 2023
Price: USD 4,900.00
The breast cancer recurrence score test is a genomic test that extracts breast cancer tissue during surgery to check the activity of certain genes...
Catalog:
MRRPB5
June 2023
Price: USD 4,900.00
HR+/HER2-Breast Cancer Highlights The global HR+HER2- Breast Cancer market was valued at US$ million in 2022 and is anticipated to reach US$ million...
Catalog:
MRRPB5
May 2023
Price: USD 2,900.00
The breast cancer recurrence score test is a genomic test that extracts breast cancer tissue during surgery to check the activity of certain genes...
Catalog:
LPI
February 2023
Price: USD 3,660.00
The breast cancer recurrence score test is a genomic test that extracts breast cancer tissue during surgery to check the activity of certain genes...
Catalog:
MRRPB5
February 2023
Price: USD 2,900.00
HR+/HER2-Breast Cancer The “HR+HER2- Breast Cancer Industry Forecast” looks at past sales and reviews total world HR+HER2- Breast Cancer sales in...
Catalog:
LPI
March 2023
Price: USD 3,660.00
